EUVIMEDEUVIMED entdecken
Scoping Review

Applications of wearable activity monitors for prostate cancer survivors: A systematic scoping review

Carolina Raines, Brandon Noorvash, Edwin Melencio Posadas, Howard M Sandler, Stephen J Freedland, Gillian Gresham

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107563 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Carolina Raines und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America. Electronic address: Carolina.Raines…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Cancer Survivors, Exercise, Wearable Electronic Devices. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Department of Defense Prostate Cancer Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Wearable technology is used to monitor and motivate physical activity (PA) and provides continuous, objective PA and sleep data outside the clinical setting. We reviewed the literature to understand how wearables are integrated into prostate cancer (PC) investigations in order to identify current practices, gaps, and research opportunities. METHODS: We conducted a literature search for articles using wearables, among PC survivors published between 2012 and 2022. We extracted study details, interventions and outcomes, participant baseline characteristics, and device characteristics and grouped them by study type: randomized control trials (RCTs) and non-randomized studies. RESULTS: Of 354 articles screened, 44 met eligibility criteria (23 RCTs, and 21 non-randomized). 89% used wearables to monitor PA metrics, 11%, sleep metrics, and 6.8%, both. Most studies involved exercise (70% RCTs, 9% non-randomized studies) or lifestyle interventions (30% RCTs, 9% non-randomized studies). Intervention delivery methods included personalized computer-based (48%), in-person (e.g., trainer) (20%), and education web or print-based (20%). Interventions occurred at the participant's home (48%) or at a gym (20%). 57% of the studies evaluated the feasibility and acceptability of the wearable as an activity-measuring device or as part of a remotely delivered computer-based intervention. Studies used wearables to monitor adherence to PA interventions, motivate behavior change, to assess patient outcomes (e.g., patient function, quality of life, mood), or as data collection tools. CONCLUSIONS: Wearables are primarily being used to assess daily activity and monitor adherence to exercise interventions in clinical studies involving PC survivors. Findings suggest that they are feasible for use in this population. More research is needed to understand how to integrate wearables into routine clinical care, expand their use to predict clinical outcomes, or to deliver tailored interventions for PC survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsCancer SurvivorsExerciseWearable Electronic DevicesHumansMaleFitness TrackersSleepQuality of LifeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Physical activityProstate cancerProstate cancer survivorshipWearable activity monitorsWearable technology

Autor:innen und Institutionen

  • Cancer Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America. Electronic address: Carolina.Raines@cshs.org.
  • Cancer Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America. Electronic address: Brandon.Noorvash@cshs.org.
  • Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America. Electronic address: edwin.posadas@csmc.edu.
  • Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America. Electronic address: Howard.Sandler@cshs.org.
  • Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America. Electronic address: Stephen.Freedland@cshs.org.
  • Cancer Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America. Electronic address: Gillian.Gresham@cshs.org.

Förderung

  • Department of Defense Prostate Cancer Research Program

Zitieren

APA

Raines, C., Noorvash, B., Posadas, E. M., Sandler, H. M., Freedland, S. J., & Gresham, G. (2024). Applications of wearable activity monitors for prostate cancer survivors: A systematic scoping review. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107563

Vancouver

Raines C, Noorvash B, Posadas EM, Sandler HM, Freedland SJ, Gresham G. Applications of wearable activity monitors for prostate cancer survivors: A systematic scoping review. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107563

BibTeX
@article{Raines2024,
  author = {Raines, Carolina and Noorvash, Brandon and Posadas, Edwin Melencio and Sandler, Howard M and Freedland, Stephen J and Gresham, Gillian},
  title = {Applications of wearable activity monitors for prostate cancer survivors: A systematic scoping review},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107563}
}
Kostenlos starten →